nonapeptide hormone
Vasopressin
Answer
Vasopressin is authorised or registered in the US, the UK, Canada, Switzerland, Brazil, Singapore and Turkey: 7 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 449 registered trials, 63 of them running. Brand names on the FDA label register: Vasopressin, Vasostrict and Vasopressin In 0.9% Sodium Chloride.
RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03
Not medical, legal or regulatory advice.
449 trials by status
Trial registerClinicalTrials.gov and EU CTIS · read 2026-10-03 · 48 trials have posted results
Trials first submitted per year
Trial registerClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 228 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).
Status by jurisdiction
World map| Where | Status | Register | Read |
|---|---|---|---|
| United States | FDA-approved | FDA, openfda | 2026-10-03 |
| European Union | Not on the register | EMA, ema | 2026-08-31 |
| United Kingdom | Authorised | MHRA, uk-mhra | 2026-10-03 |
| Canada | Authorised | Health Canada, ca-dpd | 2026-10-03 |
| Australia | Status unknown | TGA, au-artg | not read |
| Switzerland | Authorised | Swissmedic, ch-swissmedic | 2026-09-03 |
| Brazil | Registado | ANVISA, br-anvisa | 2026-10-03 |
| Serbia | Not on the register | ALIMS, rs-alims | 2026-09-03 |
| Singapore | Registered | HSA, sg-hsa | 2026-09-03 |
| Turkey | Ruhsatli | TITCK, tr-titck | 2026-09-03 |
An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.
CHANGE ALERTS
Get an email when this changes
One email when the status of Vasopressin changes on the register. You confirm your address first.
REGISTERED TRIALS
Newest 10 of 449 trials
| NCT07102615 | Intracervical Vasopressin currently recruiting participants · register updated 2026-10-02 |
|---|---|
| NCT05958342 | CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial currently recruiting participants · register updated 2026-09-29 |
| NCT07838493 | Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention currently recruiting participants · register updated 2026-09-24 |
| NCT04501861 | Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients: completed · register updated 2026-09-01 |
| NCT06635629 | Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome currently recruiting participants · register updated 2026-08-31 |
| NCT06709573 | Early Versus Late Adjunctive Vasopressin in Septic Shock currently recruiting participants · register updated 2026-08-31 |
| NCT07252401 | Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction not yet recruiting participants · register updated 2026-08-27 |
| NCT07576036 | International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osm enrolling by invitation only · register updated 2026-08-26 |
| NCT07776977 | Bedtime Device Restriction and Desmopressin in PMNE. currently recruiting participants · register updated 2026-08-24 |
| NCT07568509 | Identifying Oxytocin Deficiency in Pediatric Patients With Pituitary Disease currently recruiting participants · register updated 2026-08-21 |
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.